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Research Article
SYMPTOM PROFILES OF DSM-IV-DEFINED REMISSION,
RECOVERY, RELAPSE, AND RECURRENCE OF
DEPRESSION: THE ROLE OF THE CORE SYMPTOMS
Henk Jan Conradi, Ph.D.,1,2∗ Johan Ormel, Ph.D.,2 and Peter de Jonge, Ph.D. 2
Background: Depression outcomes in research and clinical practice are com-
monly defined by the concepts of remission, recovery, relapse, and recurrence.
Despite their widespread use, there has been little empirical examination of these
concepts. Therefore, we investigated profiles of individual symptoms during each
of these phases of depression. Methods: In a 3-year prospective study of 267
depressed primary care patients, we established the presence or absence of the in-
dividual DSM-IV depressive symptoms week-by-week during DSM-IV-defined
remissions, recoveries, relapses, and recurrences. We measured symptoms in 12
quarterly assessments using the Composite International Diagnostic Interview.
Results: Remissions were characterized by double the proportion of time that the
core symptoms were present compared to the initial phase of recoveries after a
major depressive episode (MDE; 59 versus 32%; Z = –3.03; P = .002). Before a
relapse, remissions again showed elevated levels of core symptoms in comparison
to the final phase of recoveries before a recurrence (58 versus 26%; Z = –2.99;
P = .003). Conclusions: Compared with the initial and final phases of recov-
eries, remissions showed a consistently higher level of core symptoms. Clinically,
this means that unresolved core symptoms in the direct aftermath of a MDE
seem to constitute a risk for relapse and should be the target of preventive or aug-
mented interventions. Depression and Anxiety 29:638–645, 2012. C© 2012
Wiley Periodicals, Inc.
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INTRODUCTION
In numerous treatment and observational studies that
have been conducted over the past decades, the course of
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depressive disorders has been commonly described using
the terms remission, recovery, relapse, and recurrence.
A conservative search of Pubmed revealed over 1,000
articles concerning depression studies that used one or
more of these terms in the title alone. Though these
constructs are widely referenced in scientiﬁc research
and clinical practice, they have rarely been empirically
evaluated.[1]
In the late 1980s, inconsistencies in the application
of these four constructs[2] led a task force to develop
deﬁnitions and operational criteria for the terms based
on observable phenomena.[3] Their deﬁnitions assumed
the constructs would reﬂect temporal symptom changes
over the patient’s lifetime,[1] or qualitative change points
that mark transitions in duration and severity of de-
pression symptoms over time. Such transitions were as-
sumed to be indicative of discontinuities in the course of
the depressive illness.[2,3] One crucial distinction is that
C© 2012 Wiley Periodicals, Inc.
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between remission and recovery. Remission is deﬁned
as a short period in which the patient has remitted from
the preceding major depressive episode (MDE). How-
ever, remissions are rather unstable and are, by deﬁni-
tion, quickly followed by a relapse, deﬁned as a revival of
the MDE preceding the remission. Recovery, however,
is deﬁned as a long lasting and, therefore, intrinsically
more stable variant of remission. Recovery may be life-
long or followed by a recurrence. Recurrence is deﬁned
as the development of a new MDE after recovery has
ended.[2,3]
In order to deﬁne each of the concepts, several propo-
sitions (depending on the assessment instrument used)
were made regarding (1) severity criteria, or the number
of symptoms present, and (2) duration criteria of symp-
tom improvement as in remissions or recoveries, or de-
terioration as in relapses and recurrences. As stated by
the task force,[3] these deﬁnitions are not evidence based
and should be viewed as hypotheses in need of empirical
study. To date, only two studies[4,5] have empirically in-
vestigated the constructs. These studies focused on the
distinction between remission and recovery. They ex-
amined various time points at which ongoing remissions
become deﬁned as recoveries in terms of their prognos-
tic value for the course of depression. Thus, they sought
to determine the length of remission after which there
is a marked decrease of the risk of the development of a
subsequent MDE.
In this study, we did not examine different duration
criteria for remission and recovery, but instead explored
remission and recovery as deﬁned by the DSM-IV dura-
tion criteria: <2 months not meeting criteria for MDE
for remission and≥2months for recovery.We chose the
DSM-IV duration criteria because it is the most widely
applied diagnostic system. Furthermore, we did not fo-
cus on the patient’s future course as a validator for remis-
sion and recovery, but instead investigated the internal
structure of remission, recovery, relapse, and recurrence
in terms of their constituting individual symptoms. We
did this for two reasons. First, we are unaware of studies
proﬁling individual symptoms in each of the four phases.
Nevertheless, this is a basic question because symptoms
are the building blocks of remission, recovery, relapse,
and recurrence. Second, we wanted to know more about
whether these four phases show different symptom pro-
ﬁles that might indicate symptom change or disconti-
nuity over the depressive course. As mentioned before,
symptom change underlies the deﬁnition of these four
constructs. Consistent ﬁndings that residual symptoms
during remission and recovery are important risk factors
for relapse and recurrence further support our focus on
symptoms.[6–8]
To bolster this symptoms-based approach, we estab-
lished a framework by which to evaluate our symptom
data. First, we conducted a plain descriptive analysis of
the four phases of depression in terms of their proﬁles
of individual symptoms.
Second, we compared the presence of the individ-
ual symptoms between the whole periods of remis-
sions and recoveries and between relapses and re-
currences to get a global impression of symptom
(dis-)continuity over the depressive course. Since recov-
eries are, by deﬁnition, periods of sustained remissionwe
expected lower levels of residual symptoms compared to
remissions.
Third, after comparing the four entire phases, we
zoomed in at important qualitative change points in the
depressive course.We examined both remissions which,
by DSM-IV deﬁnition, are followed within 8 weeks by
a MDE (relapse), and recoveries, which may be fol-
lowed by a MDE (recurrence) after at least 8 weeks
or any time point thereafter which can be years. Be-
cause of this variable duration of recoveries, we com-
pared remissions with two critical subphases of recov-
eries (Fig. 1). First, we compared remissions with the
initial phase of recovery, which happens in the direct af-
termath of a MDE and is the start of a long period of
presumed sustained improvement. As mentioned, resid-
ual symptoms often play a profound role in triggering
subsequent MDEs. Therefore, we anticipated remis-
sions to be characterized by elevated levels of residual
symptoms compared with the initial phase of recover-
ies, since relapses will soon follow remissions, whereas
recurrences, in the case of recoveries, will not (Com-
parison 1). Second, we compared remissions with the
ﬁnal phase of recovery, just before recurrence. We ex-
pected comparable levels of residual symptoms during re-
missions and the ﬁnal phase of recoveries because, in
both cases, a MDE (a relapse or recurrence) is pending
(Comparison 2).
MATERIALS AND METHODS
SETTING, PATIENTS, AND INCLUSION
CRITERIA
Patients participated in a 3-year randomized clinical trial in
a primary care setting (INSTEL) evaluating the effects of four
treatments.[9] We included patients suffering from a current or re-
cent MDE, occurring in the past 12 weeks, who were referred by their
General Practitioner (GP), were between 18–70 years old, and were
not suffering from a life-threatening medical condition, psychotic or
bipolar disorder, dementia, or alcohol or drug dependency. We also
excluded patients who were pregnant or already receiving psychother-
apy.
The trial consisted of four interventions: Usual Care by the GP
(UC; n = 72), a Psycho-Education Prevention program (PEP; n =
112), and PEP plus either psychiatric consultation (PC + PEP; n =
39) or brief cognitive behavioral therapy (CBT + PEP; n = 44). The
number of patients per intervention was unequal because we antici-
pated differences in treatment effects. CBT + PEP and PC + PEP
were expected to have greater effect than PEP alone in comparison to
UC. UC, given by the GP, consisted of brief supportive counseling,
possible antidepressant prescription, and/or referral according to clin-
ical guidelines. PEP was a low-intensity program consisting of three
face-to-face sessions and short quarterly telephone contacts thereafter.
In the PC + PEP condition, one session with a psychiatrist preceded
PEP, whereas in CBT + PEP on average 10 sessions of CBT were
provided prior to PEP.
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Figure 1. Comparisons between specific phases of depression (bold).
Comparison 1 (aftermath): In the aftermath of a MDE, remissions will have elevated symptom levels compared to the initial phase of
recoveries.
Comparison 2 (prelude): During the prelude to an oncoming MDE, remissions, and the final phase of recoveries will have comparably
elevated symptom levels
INSTRUMENT
At baseline, we administered the lifetime version of theComposite In-
ternational Diagnostic Interview (CIDI) face-to-face. The CIDI[10,11] is
a structured psychiatric interview that has shown good reliability and
validity.[12,13] After baseline, patients participated in quarterly tele-
phone interviews, which included an adapted CIDI depression section.
We established the presence of each of the individualDSM-IV criteria,
or symptom clusters, of depression during each week in the previous
three months. Item parcels were created by counting the symptom
group as present if any one of the symptoms that form the DSM-
IV criterion were present. These symptom clusters include the two
core symptoms of depression, depressed mood (feeling sad or empty),
and/or diminished interest (or pleasure in activities), and the seven
other symptom clusters: eating problems (weight gain or loss, and/or
changes in appetite); sleeping problems (insomnia or hypersomnia);
psychomotor problems (psychomotor agitation or retardation); fatigue
or loss of energy; feelings of worthlessness and/or guilt (beyond mere
self-reproach or guilt about being depressed); cognitive problems (di-
minished ability to think or concentrate and/or indecisiveness); and
death ideations (recurrent thoughts of death and suicide). Based on
this data on the week-by-week presence of individual symptoms, we
were able to establish whether or not patients met criteria for DSM-
IV-deﬁned remission, relapse, recovery, and recurrence during each
week of the follow-up period.
The interviewers who administered the quarterly telephone inter-
viewswere trained extensively by two supervisors who had been trained
at the ofﬁcialWHO-CIDI Training and Reference Center at the Aca-
demic Medical Center in Amsterdam. Interviewers were supervised
around once every 3 months. In order to support recall of individual
symptoms over the preceding 3months, interviewers provided respon-
dents with their record of symptoms at the moment of the previous
interview, that is, at the start of the previous 3 months. Subsequently,
respondents were asked whether each symptom present had persisted
the whole 3 months and, if not, how many weeks ago it resolved. If the
symptom was not present at the start, respondents were asked whether
it remained absent the whole 3 months and, if not, how many weeks
ago the symptom developed, whether it persisted and, if not, when it
resolved.
OUTCOME MEASURES
We deﬁned the concepts of remission, relapse, recovery, and re-
currence in accordance with the consensus paper[3] combined with
severity and duration criteria from the DSM-IV. Thus MDEs, re-
lapses and recurrences, were deﬁned as two or more consecutive
weeks in which the patient suffered from at least ﬁve out of nine
DSM-IV-deﬁned depressive symptoms, including at least one of the
core symptoms. In the DSM-IV, a time frame of 2 months is applied as
demarcation between a single episode of depression and recurrent de-
pression. The latter refers to two distinct MDEs that are by deﬁnition
separated by recovery. Remissionwas therefore deﬁned as between two
to eight consecutive weeks without aMDE, and relapse as a MDE that
started within remission. Recovery was deﬁned as at least 8 consecutive
weeks without a MDE, and recurrence as a MDE that started within
recovery. Remissions and recoveries may be partial, with patients suf-
fering from residual symptoms.
During every phase, we computed the duration of the presence of
each DSM-IV symptom cluster that patients reported. The propor-
tions of time during which patients met the criteria for each symptom
were added to compute ameasure for the overall severity in each phase.
STATISTICAL ANALYSES
First, symptom proﬁles of the four phases were determined by cal-
culating the proportion of time that each of the symptoms was present.
Second, we compared durations of individual symptoms between
remissions and recoveries, and between relapses and recurrences, using
Mann–Whitney nonparametric unrelated-samples tests. To determine
the comparability of the symptom proﬁles, we computed Spearman’s
ρ nonparametric correlation coefﬁcients between the rank order of
symptom durations between remissions and recoveries, and between
relapses and recurrences.
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We used the same type of analyses for both the a priori Compar-
isons 1 and 2.We appliedMann–Whitney nonparametric two-related-
samples testswithin groups of patients. This enabled us to compare du-
rations of symptoms during remissions and the initial and ﬁnal phases
of recoveries in the same patients. To make unbiased comparisons, we
compared a patient’s remission to the initial and ﬁnal phases of recov-
ery curtailed to the same duration as the remission. For example, if a
patient reported a remission of 5 weeks followed by a relapse, we com-
pared the remission to the initial and ﬁnal 5 week period of recovery for
that patient. Again, we computed Spearman’s ρ nonparametric corre-
lation coefﬁcients between rank order of symptoms during remission
and the initial and ﬁnal phases of recovery. To correct for multiple
testing, we set the signiﬁcance level for all analyses at P < .01 (two
tailed).
Finally, we performed sensitivity analyses to rule out possible treat-
ment effects that could explain our ﬁndings. In the original study,[9] no
differences were found between treatments during a 3-year follow-up
on any of the CIDI-based outcomes, which was themeasure of interest
in this study. However, a relatively small difference emerged on the
Beck Depression Inventory (BDI) between UC and PEP compared to
PC + PEP and CBT + PEP. Therefore, we also conducted compar-
isons within both these subgroups separately. We combined UC with
PEP, and PC + PEP with CBT + PEP and compared whether the





Table 1 shows sociodemographic and clinical charac-
teristics of the sample. At baseline, there were no dif-
ferences between treatment groups on these character-
TABLE 1. Sociodemographic and clinical characteristics
at baseline
n = 267



















Recurrent episode (DSM-IV) 67.2%
>3 previous episodes (DSM-IV) 36.8%
Antidepressant medication 74.2%
Comorbid anxiety disorder (DSM-IV) 37.8%
istics, apart from the ﬁnding that signiﬁcantly more UC
patients were married than CBT + PEP patients (F =
8.08;P= .04), and somewhatmoreUCpatients reported
severe depression at baseline compared to PEP patients
(F = 7.76; P = .02). Nonresponse for the 12 quarterly
telephone interviews ranged from 8.9% to on average
20%. Loss to follow-up was not associated with patient
characteristics at baseline. See the original study for fur-
ther details.[9]
ALL PERIODS OF REMISSION, RECOVERY,
RELAPSE, AND RECURRENCE
Table 2 shows the proportions of time that individ-
ual symptoms were present during all combined peri-
ods of remission (n = 88), recovery (n = 230), relapse
(n = 55), and recurrence (n = 126). Apart from the
core symptoms, the longest lasting were cognitive prob-
lems, sleeping problems, and lack of energy, followed
by feelings of worthlessness/guilt and eating problems.
The least prevalent symptoms were recurrent thoughts
of death and psychomotor problems. The mean dura-
tions of relapses and recurrences were comparable (11
and 14 weeks, respectively), whereas recoveries lasted far
longer than remissions (67 and 4 weeks, respectively).
Next, we usedMann–Whitney nonparametric tests to
compare the durations of individual symptoms and that
of all symptoms combined, between relapses and recur-
rences. This revealed one statistically signiﬁcant differ-
ence, namely on psychomotor problems (46 versus 26%;
Z = –2.96; P = .003). The Spearman’s ρ correlation co-
efﬁcient between the rank order of individual symptoms
during relapses and recurrences was 1.00 (P < .001).
Comparisons between remissions and recoveries re-
vealed differences on the core symptoms (53 versus 15%;
Z= –3.97;P< .001), cognitive problems (60 versus 41%;
Z= –2.75;P= .006), death ideations (13 versus 10%;Z=
–2.73; P = .006), and severity of overall symptomatology
(3.33 versus 1.85; Z = –7.83; P < .001). The Spearman’s
ρ correlation coefﬁcient between the rank order of indi-
vidual symptoms during remissions and recoveries was
.74 (P < .04).
REMISSIONS AND THE INITIAL AND FINAL
PHASES OF RECOVERIES
First, we compared remissions with the initial phase of
recoveries. We matched the length of the initial phase
with that of the remission in the same patient (Compar-
ison 1). Table 3 shows the durations of individual symp-
toms. The proportion of time that core symptoms were
present was signiﬁcantly greater during remissions than
during the initial phase of recoveries (59 versus 32%;Z=
–3.03; P = .002). Overall residual severity did not differ
signiﬁcantly. The Spearman’s ρ correlation coefﬁcient
between the symptom rank order was .93 (P = .01).
Next, we compared remissions with the ﬁnal phase of
recoveries (Comparison 2). Again, we matched the pe-
riod of the ﬁnal phase of the recoveries to the duration
of the patient’s remission. Results (Table 4) reveal that
Depression and Anxiety





























































































































































































































































































































































































































































































































































































































































































































































































































































5) the proportion of time that core symptoms were present
during remissions was signiﬁcantly greater than during
the ﬁnal phase of recoveries (58 versus 26%; Z = –2.99;
P = .003), and that overall severity was higher (3.45 ver-
sus 2.67; Z = –1.99; P = .006). The Spearman’s ρ corre-
lation coefﬁcient between the symptom rank order was
.86 (P = .007).
DISCUSSION
This study is the ﬁrst to examine the symptom pro-
ﬁles of remission, recovery, relapse, and recurrence. We
found signiﬁcant differences between remissions and
recoveries, whereas relapses and recurrences resemble
each other closely in duration and overall level of in-
dividual symptoms as well as the rank order of these
symptoms. In the following, we discuss conceptual and
clinical implications of these ﬁndings, after addressing
limitations and strengths of the study.
LIMITATIONS AND STRENGTHS
One potential limitation to this study is that we did not
differentiate between depressed mood and diminished
interest. It may be interesting to examine whether one
of the core symptoms is more responsible than the other
for the difference found between remissions and recov-
eries. However, since both depressed mood and dimin-
ished interest refer to restricted motivation, we believe
it is unlikely that this difference is decisive. Another lim-
itation is that we did not examine interrater agreement
on the presence or absence of symptoms. A ﬁnal limita-
tion may be that patients participated in a randomized
controlled trial (RCT). Despite that, previously no dif-
ferences were found between treatments on any of the
CIDI-based outcomes.[9] Moreover, this study ruled out
possible treatment effects by conducting sensitivity anal-
yses.We testedwhether treatment conditions (UC com-
bined with PEP, and PC + PEP combined with CBT +
PEP) were associated with the duration that individual
symptoms were present. These tests showed no associa-
tion.
An important strength of this study is its week-by-
week assessment of individual symptoms by quarterly
interviews over a 3-year follow-up. Compared with the
earlier empirical studies of the four constructs,[4,5]our
assessments were more regular. Also, rather than ap-
plying a cut-off based on depression severity scores,[4]
we operationalized the four constructs, using the pre-
cise DSM-IV deﬁnitions based on presence/absence of
individual depressive symptom clusters. With this we
were able to make a novel contribution, namely insight
into the structure of remissions, recoveries, relapses, and
recurrences in terms of the percentage of time that in-
dividual symptoms are present. Furthermore, analyses
in this study examined aspects of all four concepts, un-
like the studiesmentioned earlier.[4,5] Finally, we studied
these constructs in a sample of depressed primary care
patients. This has never been done before, though the
Depression and Anxiety






















































































































































































































































































































































































































































































































































































































































vast majority of depressed patients are treated in primary
care.[14]
CONCEPTUAL IMPLICATIONS
As expected, the comparison between remissions and
the full periods of recoveries revealed a signiﬁcantly
lower level of combined symptoms (3.33 versus 1.85).
This was due to differences in the presence of the core
symptoms (53 versus 15%), cognitive problems (60 ver-
sus 41%), and death ideations (13 versus 10%). This val-
idates the conceptual idea of DSM-IV-deﬁned recovery
as a sustainedperiod of improvement,whereasDSM-IV-
deﬁned remission is less stable, with considerable resid-
ual symptoms. Furthermore, recoveries were found to
last much longer than remissions (67 versus 4 weeks,
respectively). Recognizing that ﬁve or more symptoms
constitute a MDE, we can consider remissions, with an
average of 3.33 symptoms, as an intermediate period of
subthreshold depression between the preceding MDE
and the subsequent relapse. In other words, this may
mean that partial remissions mark ongoing MDEs that
are only temporarily subthreshold.
This difference between remissions and recoveries ap-
pears immediately after the preceding MDE has re-
solved, as suggested by comparing remissions and the
initial phase of recoveries (Comparison 1). This seems
due to a doubled duration of core symptoms during re-
missions compared to the initial phase of recoveries. The
lower presence of the core symptoms during the initial
phase of recoveries may indicate more stable improve-
ment, which accords with the concept of recovery and
suggests a qualitative change point in the aftermath of a
MDE.
However, the comparison between remissions and the
ﬁnal phase of recoveries (Comparison 2) resulted in an
unexpected ﬁnding. Based on earlier ﬁndings that resid-
ual symptoms are important triggers of MDEs, we ex-
pected remissions and the ﬁnal phase of recoveries to
show comparable (i.e., elevated) levels of residual symp-
toms since, in both cases, a MDE is pending. However,
we found lower levels of all symptoms combined, and of
the core symptoms in particular, during the ﬁnal phase
of recoveries. Our results seem to suggest that recur-
rences and relapses do not develop identically. Relapses,
following remissions, may be seen as a development of
residual symptoms that are unresolved during remission.
Recurrences, on the contrary, seem to develop more un-
expectedly, since the level of symptoms was signiﬁcantly
lower during the ﬁnal phase of recoveries than during re-
missions (2.67 versus 3.45). It might be that recurrences
are more suddenly triggered by new stressful events in-
stead of a build up of dormant symptoms, as seems to be
the case with relapses.
Taken together, DSM-IV-deﬁned recoveries seem to
be different from remissions as indicated by (1) dif-
ferences in symptom ranking, and (2) lower levels of
residual symptoms in general and of core symptoms in
particular. These differences are evident immediately
Depression and Anxiety


















































































































































































































































































































































































































































































































































































































































in the aftermath of aMDE.Thus, stability comes quickly
in case of recoveries, suggesting a qualitative change
point. Furthermore, the differences remain during the
ﬁnal phase of the recovery, suggesting different triggers
for the oncoming MDE.
It should be noted that since the operationaliza-
tion of remission and recovery by the task force, dif-
ferent deﬁnitions, based on the severity of symptoms,
have appeared in the literature.[15] Our study was not
able to validate these different deﬁnitions against each
other, and we recommend this as a subject for future
research.
We found no differences in symptom duration be-
tween DSM-IV-deﬁned episodes of relapse and recur-
rence. Only psychomotor problems seemed to be more
prevalent during recurrences (46 versus 26%); a ﬁnd-
ing for which we do not have an explanation other
than chance. Despite this difference, symptom rank-
ings were identical. This may suggest that, from the
perspective of symptom proﬁles, the concepts of re-
lapse and recurrence are interchangeable. The distinc-
tion between relapses and recurrences remainsmeaning-
ful in the broader conceptual framework since they are
each associated with different subthreshold phases in the
course of depression, that is, remissions and recoveries,
respectively.
CLINICAL IMPLICATIONS
Because residual symptoms are often found to be im-
portant predictors ofMDEs,[6–8] it is highly relevant that
we were able to identify the core symptoms in particular,
as residual symptoms of interest in predicting relapses.
Both depressed mood and diminished interest may refer
to limited motivation of the patient as causal or mainte-
nance factor. This may mean that remitted patients suf-
fering from depressed mood and/or diminished interest
have difﬁculty staying active, which may support the de-
velopment of other depressive symptoms. This, in turn,
may increase the risk of rapidly developing full-blown
depression, more so than in patients with normal mood.
Clinicians should view the presence of one or both of
the core symptoms in patients who are subsyndromal as
alarming, and make this the primary focus of preventive
intervention.
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